updat forecast estim aug
conduct analyst
govern code ethics/cod conduct
polici secur trade polici
equival invest research
interest visit
primari analyst cover compani
stock
research aug
estim aug
price data aug
rate updat aug
currenc amount express
busi strategi outlook
methodolog valu compani
busi strategi outlook
zoeti clear leader global anim health industri
believ possess widest moat competitor
industri whole possess mani characterist
conduc moat zoeti global infrastructur give cost
advantag peer firm also fend competit
innov show impress expans
product portfolio includ number drug specif
canin felin ailment
anim health industri larg ignor
busi often buri within larger human health compani
mani attract characterist includ cash-pay
buyer fragment custom base minim gener
competit due fragment cash-pay custom base
anim drugmak hold signific price power human
health side firm tradit merci payer
govern payer larg managed-car firm pharmaci
benefit manag power forc gener util
squash price increas even extrem case forc price cut
onto drug manufactur howev anim health product
purchas fragment group protein produc
veterinarian pet owner allow littl bargain
power highli concentr anim health firm
industri also benefit favor growth tailwind
allow zoeti increas revenu mid-single-digit
long-term growth rate product anim side rise
standard live emerg market lead wider
adopt meat-heavi diet drive greater demand livestock
product companion side zoeti benefit pet owner
increasingli strong relationship pet member
famili drastic increas willing pay
expens treatment zoeti like grow rate rel
close industri abl maintain
above-averag margin due scale especi emerg
market zoeti scale allow use salesforc
smaller competitor often forc reli expens
valuat summari forecast
financi summari forecast
historical/forecast data sourc morningstar estim may reflect adjust
zoeti sell anti-infect vaccin parasiticid diagnost
health product anim firm earn total revenu
product anim cattl pig poultri companion
anim dog hors cat product make remaind firm
largest market share industri previous anim
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
zoeti post strong second-quart result exceed
expect weve rais fair valu estim
per share incorpor optimist
nonetheless share recent trade near
stock still look overvalu us much anim
health nich follow sever transact
last year weve long admir wide moat
zoeti enjoy scale compel cost structur
leav competitor elanco dust also
take stock well zoeti execut
focu discoveri commerci companion
anim therapeut contempl turn zoetiss moat
trend posit firm strengthen intang asset
abil innov companion anim market
display hallmark matur busi weve
seen zoeti chang plot stori introduct
novel dermatolog product apoquel cytopoint
dog consid consider unmet need
among dog cat think plenti target
zoeti pursu importantli think zoeti free
focu prospect competitor remain
subsidiari larger human pharmaceut firm
merck boehring remain constrain
abil invest canine- feline-specif applic
strong oper growth across companion
anim portfolio geographi driven addit
abaxi strength dermatolog parasiticid
particularli impress quarterli
oper growth companion anim intern
market nearli match year-over-year
domest companion anim
intern didnt benefit nearli much abaxi
weak link remain china continu wrestl
african swine fever led large-scal cull
herd -- estim rang may
see much improv market
meantim zoeti benefit robust growth
larg intern market includ brazil germani
japan
boost fair valu estim per share
reflect slightli optimist project
companion anim growth next four year
improv profit longer term thank new
product well cash flow realiz sinc last updat
estim low-double-digit annual growth
companion anim segment
drive total revenu growth period
project growth earn interest
long term
ration
remain favor profit gain follow
product portfolio
invest brand companion anim drug busi
project adjust oper margin reach
basi point next five year
expect improv split nearli evenli
gain gross margin thank slim
product portfolio product anim consolid
manufactur site half driven
effici deploy sale field support howev
benefit firm effici program
slightli off-set lower-margin emerg market make
grow portion zoeti sale well greater
 invest maintain brand drug innov
whole project factor translat
adjust averag annual earn growth
base averag volatil cash flow divers
product portfolio anim health market rate
zoeti uncertainti medium
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
will pay premium buy firm trust
zoeti also enjoy anoth intang asset comparison
competitor embed larger human
pharmaceut firm zoeti free develop therapeut
base unmet anim need competitor applic
therapeut origin design human anim
market also mean firm unlik invest
animal-specif therapi sizabl opportun
relat unmet anim need zoeti pioneer
includ cytopoint canin allergi
scale also provid zoeti key advantag
highli fragment custom base salesforc
distribut relationship extrem import
launch new product simpl get one
larg payer managed-car organ medicar
govern board compani need individu
deal veterinarian meat produc zoeti broad
portfolio support salesforc allow firm
bypass distributor
barrier entri signific capit time
although nearli expens time-consum
human health still challeng bring new
anim health product market given small market
size rel modest sale potenti product
reward often justifi new competitor pursu
clinic trial bring product market
believ zoeti stabl moat trend compani
compet matur industri experienc
signific chang even spin-out eli lilli
anim health unit elanco consid heavi
concentr among top firm revolutionari
product develop expect industri
face materi chang competit landscap
base case forecast long-term tax rate
long-term oper margin firm
abl boost sale product anim product
leverag greater price power companion anim
portfolio project adjust oper margin beyond
fair valu estim would per share
firm lose revenu due greater
restrict antibiot use anim improv
oper margin basi point penetr
emerg market pressur profit fair valu
would fall per share
zoeti enjoy wide econom moat thank intang
asset scale although patent essenti
maintain product anim health industri least
firm revenu come product protect
patent allow zoeti charg premium price
insul competit firm strong brand name
anoth advantag competitor custom
use drug potenti million dollar worth
livestock pet love like famili member
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
ogrow interest probiot antibacteri peptid
immun modul altern antibiot
offer mani target innov
ostrict regul restrict antibiot use
ocompanion anim increasingli view famili
spend pet healthcar
olower-margin emerging-market sale make
increas portion compani sale creat
headwind zoeti margin
osinc anim health industri lack larg payer
like medicar single-pay govern larg
oemerging-market custom may price-
sensit open use gener product
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
equival begin period
total avail debt servic
oblig commit
total oblig commit
adjust free
gener
gener revolv adjust
commit
zoeti enjoy solid financi flexibl even leverag
tick financ purchas pharmaq
abbott anim health busi long-term debt
billion end zoeti alreadi brought
debt/ebitda time time three
year expect leverag land low end
target rang time end year
remain comfort interest coverag around time
base averag volatil cash flow divers
product portfolio anim health market rate
zoeti uncertainti medium thank grow consum
medic concern use antibiot
food suppli food drug administr
meat product industri final begun react
industri alreadi roll new standard call
voluntari monitor use anim howev
grassroot pressur continu build risk
fda could eventu issu restrict guidelin
product anim segment offer rel
steadi growth remain expos macroeconom trend
emerg market adopt higher-protein diet
like fuel underli demand zoeti product
slower growth china brazil rippl effect could
reach zoeti companion anim market price
elast pet health care clear pet owner continu
spend pet point rise price
may owner will bear
segment market vulner macroeconom
downturn caus consum pull back spend
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
base nearli three year sinc zoeti spun
give firm standard stewardship rate
ceo juan ramon alaix previous ran busi
presid anim health busi firm
separ leadership anim health unit
success integr fort dodg anim health
alpharma acquisit region
presid central/southern europ
pharmaceut divis believ seven year run
compani give signific oper experi
thu far alaix focus increas zoeti scale
breadth seri acquisit allow
firm enter adjac market includ aquacultur
monoclon antibodi pet
abrupt departur former cfo paul herendeen
valeant current cfo glenn david prove
highli compet role david longtim
veteran deep experi healthcar
well acquisit integr new busi
expect see dramat departur
firm current strategi serial acquisit though leverag
settl lower expect
herendeen aggress stanc
repres date owner name posit common share held report holder issuer
capit research manag compani
new york mellon corp
share
fund
share
fund
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
zoeti post strong second-quart result exceed
expect weve rais fair valu estim
per share incorpor optimist
nonetheless share recent trade near
stock still look overvalu us much anim
health nich follow sever transact
last year weve long admir wide moat
zoeti enjoy scale compel cost structur
leav competitor elanco dust also
take stock well zoeti execut
focu discoveri commerci companion
anim therapeut contempl turn zoetiss moat
trend posit firm strengthen intang asset
abil innov companion anim market
display hallmark matur busi weve
seen zoeti chang plot stori introduct
novel dermatolog product apoquel cytopoint
dog consid consider unmet need
among dog cat think plenti target
zoeti pursu importantli think zoeti free
focu prospect competitor remain
subsidiari larger human pharmaceut firm
merck boehring remain constrain
abil invest canine- feline-specif applic
strong oper growth across companion
anim portfolio geographi driven addit
abaxi strength dermatolog parasiticid
particularli impress quarterli
oper growth companion anim intern
market nearli match year-over-year
domest companion anim
intern didnt benefit nearli much abaxi
weak link remain china continu wrestl
african swine fever led large-scal cull
herd -- estim rang may
see much improv market
meantim zoeti benefit robust growth
larg intern market includ brazil germani
japan
zoeti deliv strong result african swine
fever put pressur livestock busi may
gener met expect foreign currenc headwind
slightli stronger wed anticip make
slight adjust near-term project reflect
stronger dollar stand behind fair valu
estim zoeti continu reinforc wide moat
anim health arena addit diagnost
abaxi saw companion anim
geograph expans behind companion anim
product portfolio especi dermatolog therapi
think zoeti see sustain robust growth
hand product anim segment face
difficult condit near term particular spread
african swine fever china introduc
disrupt market manag estim
million pig china lost estim
think may higher end nonetheless still
lot pig compar million american
farmer produc largest pork market weve alreadi
seen shock emerg lean pork price think
bottom januari chines farmer slaughter
pig decemb effort get ahead outbreak
sinc februari price jump dramat
expect cull damp zoeti swine busi
next coupl quarter meantim agre
manag content global produc
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
administ monthli vet mani part
countri recommend owner keep dog heartworm
prevent year-round think inject
last month could conveni option longer
length efficaci substanti improv zoeti
exist proheart vaccin last six month
one area soft like worsen
cattl beef dairi herd exit all-tim
demand seem soften could see market
weaken year base manag remark
zoeti expect headwind market
off-set strength swine poultri aquacultur
ramp pork product meet chines demand
howev could take roughli year estim
thu anticip near-term pressur swine
eas growth brazil unit state swine
product gain strength
zoeti flex wide moat muscl chang
fve feb
zoeti report fourth-quart full-year perform
slightli outpac estim top line
off-set modestli higher manufactur sale
market expens make small adjust
model plan leav fair valu estim unchang
demonstr evid wide econom moat
robust pipelin featur new product offer novel
benefit think partial reflect
zoeti expertis manag product life cycl also
think firm done nice job take animal-
center approach innov weve discuss
anim health therapeut often
consid potenti applic human use
pharmaceut compani zoeti freedom
devot develop resourc animal-specif issu
product portfolio reflect orient
organ part
come fourth quarter saw oper
revenu growth basi point volum
price respect think zoeti remain good
posit meet expect particular
new fostera gold pcv mh vaccin swine see
revolut cat novel inject heartworm
protect deck launch year find
latter especi intrigu popular
heartworm prevent oral chewabl must
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
financi summari forecast
fiscal year end decemb
earn interest tax
return asset
return equiti
valuat summari forecast
equiti
pre-tax debt
weight averag capit
addit estim scenario avail download http //select morningstar com
equival
data tabl repres base-cas forecast compani report
currenc begin current year fair valu estim may differ
equiti valu per share shown due time valu money adjust case
probability-weight scenario analysi perform
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
fiscal year end decemb
good sold
depreci amort report separ
impair charg report separ
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
